13.07.2015 Views

marker-assisted selection in wheat

marker-assisted selection in wheat

marker-assisted selection in wheat

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 1 – An overview of the issues 11Economic factorsAs with any new technology promis<strong>in</strong>g<strong>in</strong>creased benefits, the costs of applicationmust also be considered. Accord<strong>in</strong>g toDekkers and Hospital (2002), “economicsis the key determ<strong>in</strong>ant for the application ofmolecular genetics <strong>in</strong> genetic improvementprogrammes. The use of <strong>marker</strong>s <strong>in</strong> <strong>selection</strong><strong>in</strong>curs the costs that are <strong>in</strong>herent to moleculartechniques. Apart from the cost of QTLdetection, which can be substantial, costsfor MAS <strong>in</strong>clude the costs of DNA collection,genotyp<strong>in</strong>g and analysis.” For example,Koebner (2003) suggested that the currentcosts of MAS would need to fall considerablybefore it would be used widely <strong>in</strong> <strong>wheat</strong>and barley breed<strong>in</strong>g. In practice, therefore,although MAS may lead to <strong>in</strong>creased geneticresponses, decision-makers need to considerwhether it may be cost-effective or whetherthe money and resources spent on develop<strong>in</strong>gand apply<strong>in</strong>g MAS might <strong>in</strong>stead bemore efficiently used on improv<strong>in</strong>g exist<strong>in</strong>gconventional breed<strong>in</strong>g programmes oradopt<strong>in</strong>g other new technologies.Little consideration has been givento this issue. Some results have, however,been published recently from studiesat the International Maize and WheatImprovement Center (CIMMYT) <strong>in</strong> Mexicoon the relative cost-effectiveness of conventional<strong>selection</strong> and MAS for differentmaize breed<strong>in</strong>g applications. One applicationconsidered by Morris et al. (2003) wasthe transfer of an elite allele at a s<strong>in</strong>gle dom<strong>in</strong>antgene from a donor l<strong>in</strong>e to a recipientl<strong>in</strong>e. Here, conventional breed<strong>in</strong>g is lessexpensive but MAS is quicker. For situationslike this, where the choice betweenconventional breed<strong>in</strong>g and MAS <strong>in</strong>volvesa trade-off between time and money, theysuggested that the cost-effectiveness ofus<strong>in</strong>g MAS depends on four parameters: therelative cost of phenotypic versus <strong>marker</strong>screen<strong>in</strong>g; the time saved by MAS; the sizeand temporal distribution of benefits associatedwith accelerated release of improvedgermplasm and, f<strong>in</strong>ally, the availability tothe breed<strong>in</strong>g programme of operat<strong>in</strong>g capital.They conclude that “all four of theseparameters can vary significantly betweenbreed<strong>in</strong>g projects, suggest<strong>in</strong>g that detailedeconomic analysis may be needed to predict<strong>in</strong> advance which <strong>selection</strong> technology willbe optimal for a given breed<strong>in</strong>g project.”In the applications considered byCIMMYT, the costs of develop<strong>in</strong>g molecular<strong>marker</strong>s associated with the trait of<strong>in</strong>terest were not considered, as it wasassumed that they were already available.There is a dist<strong>in</strong>ction between developmentcosts (e.g. identify<strong>in</strong>g molecular <strong>marker</strong>s onthe genome, detect<strong>in</strong>g associations between<strong>marker</strong>s and the traits of <strong>in</strong>terest) andrunn<strong>in</strong>g costs (typ<strong>in</strong>g <strong>in</strong>dividuals for theappropriate <strong>marker</strong>s <strong>in</strong> the <strong>selection</strong> programme)of MAS. Development costs canbe considerable, so develop<strong>in</strong>g countriesneed to consider whether to develop theirown technology or, alternatively, to importthe technology developed elsewhere, ifavailable.Another aspect to be considered is how toevaluate the economic benefits of MAS. Fora publicly-funded breed<strong>in</strong>g programme, itshould <strong>in</strong>clude economic benefits to farmersfrom genetic improvement of their plants oranimals. For private companies on the otherhand, the impacts of us<strong>in</strong>g MAS on theirmarket share, and not on rates of geneticimprovement, would be of greatest <strong>in</strong>terest.The economics of MAS are considered<strong>in</strong> more detail later, <strong>in</strong> particular <strong>in</strong>Chapter 19.MAS versus conventional methodsAlthough conventional breed<strong>in</strong>g programmesthat rely on phenotypic records

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!